Physician profile
Jeffrey Horowitz
NPI 1457355000
$2,603.48
in general payments reported to CMS, 2019-2025
22 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $95.85 · 2021: $210 · 2022: $230 · 2023: $231 · 2024: $792 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $381.48 | 2019-2022 | |
| Paragon 28, INC. | $299.94 | 2024 | Ankle Fracture, Phantom Hindfoot |
| Medshape, INC. | $283.80 | 2023-2024 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail Helix, Washer, 15 Mm |
| Integra Lifesciences Corporation | $221.18 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $190.23 | 2020-2022 | |
| Stryker Corporation | $149.86 | 2019-2025 | Prostep Mica |
| Advanced Oxygen Therapy INC. | $140.00 | 2024 | Topical Oxygen Chamber For Extremities |
| Melinta Therapeutics, LLC | $124.52 | 2019 | |
| Celgene Corporation | $123.55 | 2019 | |
| Paratek Pharmaceuticals, INC. | $120.36 | 2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $110.24 | 2019 | |
| Biocomposites INC | $94.45 | 2025 | Stimulan |
| Crossroads Extremity Systems, LLC | $93.34 | 2019 | |
| Trilliant Surgical LLC. | $60.01 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Tenex Health INC. | $49.84 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $48.82 | 2021-2024 | |
| Heron Therapeutics, INC. | $27.58 | 2021-2022 | |
| Medtronic, INC. | $19.68 | 2023 | Venaseal |
| Ani Pharmaceuticals, INC. | $19.63 | 2025 | Purified Cortrophin Gel |
| Bone Support INC. | $17.17 | 2024 | Ceramentbone Void Filler, Cerament G |
| Sebela Pharmaceuticals INC. | $14.63 | 2020 | |
| Merck Sharp & Dohme LLC | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.